DexCom’s fair value price target has been tweaked from US$85.85 to US$86.12 per share, a small shift that still matters if you are tracking what analysts are baking into their models. This move sits ...
In 2026, consumer wearables do more. They can flag patterns that may point to real health problems, not just a rough wellness trend.
People don't buy consumer wearables just to count steps anymore. They want early warnings, useful health signals, and features they can trust.
Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...
At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results